Hammad Jafri S, Qureshi Reema, Ho Tiffany Tin T, Chung Hojune E, Ngamdu Kyari Sumayin, Medbury Elizabeth, Ursillo Jeannie, Robitaille Jennifer, Wu Wen-Chih
Providence Veterans Affairs Medical Center, Providence, RI; Alpert Medical School, Brown University, Providence, RI.
Alpert Medical School, Brown University, Providence, RI.
Curr Probl Cardiol. 2023 Dec;48(12):102013. doi: 10.1016/j.cpcardiol.2023.102013. Epub 2023 Aug 5.
Patients with Heart Failure (HF) have significant morbidity and mortality. Home Based Cardiac Rehabilitation (HBCR) is a form of Cardiac Rehabilitation (CR) which has been proven beneficial for the patients with cardiovascular disease; However, cardiovascular outcomes in patients with HF who was referred to HBCR is not known.
A retrospective study of 188 patients with HF (HFrEF or heart failure with reduced ejection fraction and HFpEF or heart failure with preserved ejection fraction) referred to HBCR at Veterans Affairs Medical Center (VAMC) from November 2017 to March 2020. We used the outcomes of patients with HF who attended HBCR and compared with the outcomes of patients who did not attend HBCR (Non-HBCR) from 3 months after starting HBCR till 12 months. Primary outcome was composite of all-cause mortality and cardiovascular hospitalizations. Secondary outcomes were all-cause mortality, cardiovascular hospitalizations and all-cause hospitalization, separately. We used cox proportional methods to calculate hazard ratios (HR) and 95% CI. We adjusted for imbalanced characteristics at baseline: age, smoking, PCI and CABG status. In subgroup analysis, we compared HFrEF and HFpEF patients who have completed HBCR and compared differences of their outcomes (weight, blood pressure, cholesterol, LDL, HDL, triglycerides, HbA1C, 6 Minutes walking test, duke score and PHQ-9) pre- and post-HBCR.
Mean age of the patients was 72 year and 98% were male. Out of 188 patients total, 11 patients were excluded for the main analysis as their outcomes occurred within first 90 days of HBCR enrollment, 105/177 (59%) patients attended HBCR while 72/177 (41%) patients did not attend HBCR and 93/105 (89%) patients have completed HBCR. The primary outcome occurred in 14 patients (13.3%) in the HBCR group and 19 patients (26.4%) in the Non-HBCR group (adjusted HR=0.32, CI 0.15-0.68). There was no difference in cardiovascular hospitalization among two groups, however patients in HBCR group have lower all-cause hospitalizations and all-cause death, separately. After HBCR completion, all outcomes (weight, blood pressure, cholesterol, LDL, HDL, triglycerides, HbA1C, 6 Minutes walking test, duke score and PHQ-9) have improved in both HFrEF and HFpEF group.
Patients with HF who have completed HBCR have a lower risk of all-cause mortality, all cause hospitalization separately and lower risk of combined all-cause mortality and cardiovascular hospitalization. Patients with HFrEF and HFpEF have equal degree of improvement after completing HBCR when compared with each other. HBCR is an ideal opportunity for patients with HF who cannot attend center-based CR and also for patients with HFpEF since CR is not approved for those patients.
心力衰竭(HF)患者具有较高的发病率和死亡率。家庭心脏康复(HBCR)是心脏康复(CR)的一种形式,已被证明对心血管疾病患者有益;然而,转诊至HBCR的HF患者的心血管结局尚不清楚。
对2017年11月至2020年3月在退伍军人事务医疗中心(VAMC)转诊至HBCR的188例HF患者(射血分数降低的心力衰竭HFrEF或射血分数保留的心力衰竭HFpEF)进行回顾性研究。我们采用参与HBCR的HF患者的结局,并与开始HBCR后3个月至12个月未参与HBCR(非HBCR)的患者的结局进行比较。主要结局是全因死亡率和心血管住院的综合指标。次要结局分别是全因死亡率、心血管住院和全因住院。我们使用Cox比例法计算风险比(HR)和95%置信区间(CI)。我们对基线时不均衡的特征进行了调整:年龄、吸烟、经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)状态。在亚组分析中,我们比较了完成HBCR的HFrEF和HFpEF患者,并比较了他们在HBCR前后的结局(体重、血压、胆固醇、低密度脂蛋白、高密度脂蛋白、甘油三酯、糖化血红蛋白、6分钟步行试验、杜克评分和患者健康问卷-9)差异。
患者的平均年龄为72岁,98%为男性。在188例患者中,11例患者因结局发生在HBCR入组的前90天内而被排除在主要分析之外,105/177(59%)例患者参与了HBCR,而72/177(41%)例患者未参与HBCR,93/105(89%)例患者完成了HBCR。主要结局在HBCR组的14例患者(13.3%)和非HBCR组的19例患者(26.4%)中出现(调整后的HR=0.32,CI 0.15 - 0.68)。两组之间的心血管住院无差异,然而,HBCR组患者的全因住院和全因死亡分别较低。完成HBCR后,HFrEF和HFpEF组的所有结局(体重、血压、胆固醇、低密度脂蛋白、高密度脂蛋白、甘油三酯、糖化血红蛋白、6分钟步行试验、杜克评分和患者健康问卷-9)均有所改善。
完成HBCR的HF患者全因死亡率、全因住院风险分别较低,全因死亡率和心血管住院综合风险也较低。与彼此相比,HFrEF和HFpEF患者在完成HBCR后有同等程度的改善。对于无法参加中心式CR的HF患者以及HFpEF患者(因为CR未被批准用于这些患者),HBCR是一个理想的选择。